Morning Market Movers
September 17, 2013 at 09:53 AM EDT
Repros Therapeutics (NASDAQ: RPRX ) moved up 26.15% to $26.82 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®. Kythera Biopharmaceuticals (NASDAQ: KYTH ) jumped 24.43% to $41.72 after the company reported positive ATX-101 top
